GCSA GLOBAL CLINICAL SITE ACCREDITATION
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GCSA GLOBAL CLINICAL SITE ACCREDITATION Trademark

Serial Number: 79371028 • Registration: 7416560

GCSA GLOBAL CLINICAL SITE ACCREDITATION is a trademark filed by Global Clinical Site Assessment Limited on January 6, 2023. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Global Clinical Site Assessment Limited (2 trademarks)

Bray Business Centre, Weir Bank,

Entity Type: 99

Trademark Details

Filing Date

January 6, 2023

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Quality evaluation, checking, auditing and assurance services in the field of clinical research site competency, practices and processes to determine conformity with certification standards; quality checking in the field of clinical trial site competency, practices and processes; quality auditing in the field of clinical trial site competency, practices and processes; quality evaluation of clinical research sites to determine conformity with established accreditation standards; quality evaluation of clinical research sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; clinical research and clinical trials quality evaluation services to determine conformity with established accreditation standards; information, advisory and consultancy services in relation to all the aforementioned services

Organisation of educational conferences, exhibitions and seminars for best practice sharing in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation all of the aforementioned services

Provision of business advice and assistance in the field of clinical trial site competency, practices and processes; gap analysis and process improvement, namely, business advice and management services, in the field of clinical trial site competency, practices and processes; human resource advice and management services in the field of clinical trial site competency, practices and processes; human resource process improvement services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services

Reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trial site competency, practices and processes; review and preparation of regulations, standards and compliance procedures being legal services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 6, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 16, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 29, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 6, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 1, 2023 REPR